Being tested
Brain or nerve stimulation: improve symptoms or function in relapsing MS
relapsing MS · Brain or nerve stimulation
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 17
- Running now
- 4
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 52
How the verdict was reached
Phase 2 results not all read yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Neuromodulation device, phase 2 | Phase 2 | 52 | 2022 | No results found | Will count once its result is read |
| TAS in RRMS | Not a drug-phase study | 12 | 2021 | Stopped | Not counted: not randomised |
| STIMASEP | Phase 3 | 66 | 2014 | No results found | Not counted: not randomised |
| Neuromodulation device, trial | Not a drug-phase study | 1 | 2018 | Stopped | Not counted: phase 1 or phase 4 |
| Neuromodulation device, trial | Not a drug-phase study | 23 | 2018 | No results found | Not counted: phase 1 or phase 4 |
| Neuromodulation device, trial | Not a drug-phase study | 21 | 2018 | No results found | Not counted: phase 1 or phase 4 |
| Neuromodulation device, phase 2 | Phase1|phase2 | 90 | 2019 | Paper found, not read | Not counted: tested as the comparator |
| REHACOG-MS | Not a drug-phase study | 0 | 2019 | Stopped | Not counted: phase 1 or phase 4 |
| Neuromodulation device, trial | Not a drug-phase study | 18 | 2022 | No results found | Not counted: phase 1 or phase 4 |
| Stimrouter | Not a drug-phase study | 23 | 2020 | No results found | Not counted: not randomised |
| Neuromodulation device, trial | Not a drug-phase study | 60 | 2023 | Still running | Not counted: phase 1 or phase 4 |
| Neuromodulation device, trial | Not a drug-phase study | 51 | 2023 | Met its main goal | Not counted: phase 1 or phase 4 |
| GVS on MS | Phase 1 | 40 | 2023 | No results found | Not counted: not randomised |
| Exercise rehabilitation, trial | Not a drug-phase study | 45 | 2024 | No results found | Not counted: phase 1 or phase 4 |
| ACULUTS | Not a drug-phase study | 150 | 2025 | Still running | Not counted: not randomised |
| Neuromodulation device, trial | Not a drug-phase study | 84 | 2026 | Still running | Not counted: phase 1 or phase 4 |
| NIBS_MSf | Not a drug-phase study | 80 | 2026 | Still running | Not counted: phase 1 or phase 4 |
Counted: 0. Will count later: 1. Not counted: 16.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026Trials: 21 → 17
- Oct 2026First listed as Being tested
Related hypotheses
- Brain or nerve stimulation: improve symptoms or function in NMOSD
- Brain or nerve stimulation: improve symptoms or function in optic neuritis
- Brain or nerve stimulation: improve symptoms or function in primary progressive MS
- Brain or nerve stimulation: improve symptoms or function in relapsing and progressive MS
- Brain or nerve stimulation: improve symptoms or function in secondary progressive MS
- Brain or nerve stimulation: improve symptoms or function in MS (type not specified)
Assembled by software from public sources.